share_log

Does Dow (NYSE:DOW) Have A Healthy Balance Sheet?

Does Dow (NYSE:DOW) Have A Healthy Balance Sheet?

道指(紐交所:DOW)的資產負債表健康嗎?
Simply Wall St ·  06/12 21:05

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know worries about.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved when a business collapses. We can see that Dow Inc. (NYSE:DOW) does use debt in its business. But the more important question is: how much risk is that debt creating?

霍華德·馬克斯很清楚地指出,與其擔心股價波動,不如擔心"永久性損失"的風險......而每位實際的投資者都有這種顧慮。當你考慮一家公司的風險程度時,考慮其資產負債表是很自然的,因爲債務通常是業務崩潰時的重要原因。我們可以看到,陶氏化學 (NYSE:DOW) 確實在其業務中使用了債務。但更重要的問題是:該債務產生了多少風險?

Why Does Debt Bring Risk?

爲什麼債務會帶來風險?

Debt is a tool to help businesses grow, but if a business is incapable of paying off its lenders, then it exists at their mercy. Part and parcel of capitalism is the process of 'creative destruction' where failed businesses are mercilessly liquidated by their bankers. However, a more usual (but still expensive) situation is where a company must dilute shareholders at a cheap share price simply to get debt under control. Having said that, the most common situation is where a company manages its debt reasonably well - and to its own advantage. The first thing to do when considering how much debt a business uses is to look at its cash and debt together.

債務是幫助企業擴大業務的工具,但如果一家企業無法償還債務,那麼它就被債權人所掌控。資本主義的必然過程就是"創造性破壞",失敗的企業被銀行家無情地清算。然而,更常見的情況(儘管仍然很昂貴)是一家企業必須以較低的股價稀釋股東權益,以便使債務得到控制。話雖如此,最常見的情況是企業合理管理其債務-並使其受益。考慮企業使用的債務有多少時,首先要做的是看其現金和債務的綜合情況。

What Is Dow's Debt?

陶氏化學的債務狀況是什麼?

You can click the graphic below for the historical numbers, but it shows that as of March 2024 Dow had US$15.5b of debt, an increase on US$14.5b, over one year. On the flip side, it has US$4.49b in cash leading to net debt of about US$11.0b.

您可以點擊下面的圖表查看歷史數據,但它顯示截至2024年3月,陶氏化學的債務爲155億美元,比一年前的145億美元增加了1個億。另一方面,它擁有44.9億美元的現金,導致淨債務約110億美元。

debt-equity-history-analysis
NYSE:DOW Debt to Equity History June 12th 2024
紐交所:DOW債務股本比歷史記錄2024年6月12日

How Healthy Is Dow's Balance Sheet?

陶氏化學的資產負債表情況如何?最新的資產負債表數據顯示,在一年內到期的陶氏化學負債爲102億美元,到期後到期的負債爲297億美元。另一方面,它擁有44.9億美元的現金和7.08億美元相當於一年內到期的應收賬款。因此,其負債總額比其現金和短期應收賬款的組合多283億美元。

The latest balance sheet data shows that Dow had liabilities of US$10.2b due within a year, and liabilities of US$29.7b falling due after that. On the other hand, it had cash of US$4.49b and US$7.08b worth of receivables due within a year. So its liabilities total US$28.3b more than the combination of its cash and short-term receivables.

這是巨大的槓桿,即使與其390億美元的巨大市值相比也是如此。這表明,如果該公司需要迅速籌集資金以支撐其資產負債表,股東們將遭受嚴重的稀釋。

This is a mountain of leverage even relative to its gargantuan market capitalization of US$39.4b. This suggests shareholders would be heavily diluted if the company needed to shore up its balance sheet in a hurry.

陶氏化學的淨債務爲EBITDA的2.2倍,這不算太多,但其利息覆蓋率看起來有點低,因爲EBIT只有利息費用的4.6倍。在很大程度上,這是由於公司的折舊和攤銷費用相當大,這可能意味着其EBITDA是一種非常慷慨的收益計量標準,而其債務可能是更大的負擔。股東們應該注意,陶氏化學的EBIT去年下降了46%。如果收益趨勢繼續下降,那麼償還債務將像把貓趕上過山車一樣困難。當你分析債務問題時,資產負債表顯然是需要關注的領域。但最終,業務未來的盈利能力將決定陶氏化學是否能夠隨着時間的推移加強其資產負債表。因此,如果你關注未來,可以查看這份免費的分析師利潤預測報告。

In order to size up a company's debt relative to its earnings, we calculate its net debt divided by its earnings before interest, tax, depreciation, and amortization (EBITDA) and its earnings before interest and tax (EBIT) divided by its interest expense (its interest cover). This way, we consider both the absolute quantum of the debt, as well as the interest rates paid on it.

爲了衡量公司債務相對於其收益的大小,我們計算其淨債務除以利息、稅、折舊和攤銷前收益(EBITDA)以及其稅前收益與利息支出(其利息覆蓋率)的比率。這樣,我們既考慮了債務的絕對量,也考慮了所支付的利率。

Dow has net debt worth 2.2 times EBITDA, which isn't too much, but its interest cover looks a bit on the low side, with EBIT at only 4.6 times the interest expense. In large part that's due to the company's significant depreciation and amortisation charges, which arguably mean its EBITDA is a very generous measure of earnings, and its debt may be more of a burden than it first appears. Shareholders should be aware that Dow's EBIT was down 46% last year. If that earnings trend continues then paying off its debt will be about as easy as herding cats on to a roller coaster. The balance sheet is clearly the area to focus on when you are analysing debt. But ultimately the future profitability of the business will decide if Dow can strengthen its balance sheet over time. So if you're focused on the future you can check out this free report showing analyst profit forecasts.

最後,一家公司只能用現金而非會計利潤償還債務。因此,我們顯然需要看看EBIT是否能帶來相應的自由現金流。在過去的三年中,陶氏化學產生了可靠的企業自由現金流,相當於其EBIT的78%,與我們的預期相當。這一自由現金流使該公司有足夠的能力適時償還債務。

Finally, a company can only pay off debt with cold hard cash, not accounting profits. So we clearly need to look at whether that EBIT is leading to corresponding free cash flow. During the last three years, Dow produced sturdy free cash flow equating to 78% of its EBIT, about what we'd expect. This free cash flow puts the company in a good position to pay down debt, when appropriate.

陶氏化學的EBIT增長率在分析中確實是一個真正的負面因素,儘管我們考慮的其他因素使其看起來更加光明。例如,它將EBIT轉化爲自由現金流的能力是令人耳目一新的。綜合考慮上述因素,我們確實認爲陶氏化學的債務對企業存在一定風險。雖然債務可以提高回報,但我們認爲公司現在的槓桿已經足夠了。在分析債務水平時,資產負債表是顯然的起點。然而,並非所有的投資風險都在資產負債表上,甚至遠非如此。請注意,陶氏化學在我們的投資分析中顯示出了4個警示信號,其中1個讓我們感到有點不舒服......

Our View

我們的觀點

Dow's EBIT growth rate was a real negative on this analysis, although the other factors we considered cast it in a significantly better light. For example its conversion of EBIT to free cash flow was refreshing. Taking the abovementioned factors together we do think Dow's debt poses some risks to the business. While that debt can boost returns, we think the company has enough leverage now. When analysing debt levels, the balance sheet is the obvious place to start. However, not all investment risk resides within the balance sheet - far from it. Be aware that Dow is showing 4 warning signs in our investment analysis , and 1 of those makes us a bit uncomfortable...

分析中,陶氏化學的EBIT增長率確是一個真正的負面因素,但我們考慮的其他因素使它看起來更有前景。例如,它將EBIT轉化爲自由現金流的能力是令人耳目一新的。綜合考慮上述因素,我們確實認爲陶氏化學的債務存在一定風險。雖然債務可以提高回報,但我們認爲公司現在的槓桿已經足夠了。在分析債務水平時,資產負債表是顯然的起點。然而,並非所有的投資風險都在資產負債表上,甚至遠非如此。請注意,陶氏化學在我們的投資分析中顯示出了4個警示信號,其中1個讓我們感到有點不舒服......

At the end of the day, it's often better to focus on companies that are free from net debt. You can access our special list of such companies (all with a track record of profit growth). It's free.

總的來說,專注於沒有淨債務的公司往往更好。您可以訪問我們的特別列表,其中包含這些公司(所有這些公司都有盈利增長的記錄)。這是免費的。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或者,發送電子郵件至editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論